Company Description
Medifast offers weight-loss programs based on clinically proven, portion-controlled meals. The plans offer customers to choose from 70 different meals, which are bought directly from Medifast. Additionally, the company offers coaching and support groups for its dieters
Another Surprise
On Aug 5 Medifast reported its sixth consecutive earnings surprise on a 60% increase in revenue. Sales were up to $66.7 million, from $41.7 million a year ago. Net income almost doubled, to $5.6 million from $3.0 million.
Earnings per shares came out to 38 cents, 18 cents better than last year and 4 cents better than Wall Street expected.
Analyst Revisions
Following the earnings surprise, the Zacks Consensus Estimate for 2010 jumped 13 cents, to $1.44. Next year's forecasts are averaging $1.75, up a dime on the news.
If Medifast can meet these expectations, year-over-year growth rates will be 78% and 21%, respectively. And you won't be overpaying for those rates, as shares are trading with a PEG ratio of just 0.8.
The Chart
The recent estimate revisions are nothing new for MED analysts. You can see below that the full-year estimates have been steadily increasing for more than 2 years.
Read the July 7th Feature Here
Bill Wilton is the Growth Stock Strategist for Zacks.com. He is also the Editor in charge of the market-beating Zacks Growth Trader service
Last Week's Aggressive Growth Zacks Rank Buy Stocks
UFP Technologies, Inc. (UFPT) posted record results in the last quarter after growing through acquisition and organically. Read Full Article.
Albany International Corp (AIN) analysts are feeling bullish after the latest earnings report. Estimates are up and the stock is a great entry point. Read Full Article.
Magellan Health Services, Inc. (MGLN) is up sharply since its latest earnings surprise. Thanks to estimate revisions, shares are still a good value and are showing stability in a rough market. Read Full Article.
AutoNation, Inc. (AN) analysts are raising estimates following the latest earnings surprise. Industry sales continue to improve and AutoNation is making the most of it.
Read Full Article.
MEDIFAST INC (MED): Free Stock Analysis Report
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.